Bora CDMO Bora CDMO

X

Find SUPVGFZUWFMATN-UHFFFAOYSA-N manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

06IVK87M04
Also known as: Pu-h71, 873436-91-0, Pu-h 71, Pu h71, Zelavespib, Puh-71
Molecular Formula
C18H21IN6O2S
Molecular Weight
512.4  g/mol
InChI Key
SUPVGFZUWFMATN-UHFFFAOYSA-N
FDA UNII
06IVK87M04

Zelavespib is a purine-based heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Zelavespib specifically inhibits active Hsp90, thereby inhibiting its chaperone function and promoting the proteasomal degradation of oncogenic signaling proteins involved in tumor cell proliferation and survival. This may result in the inhibition of cellular proliferation in susceptible tumor cell populations. Hsp90, a molecular chaperone protein, is upregulated in a variety of tumor cell types.
1 2D Structure

06IVK87M04

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine
2.1.2 InChI
InChI=1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23)
2.1.3 InChI Key
SUPVGFZUWFMATN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C)NCCCN1C2=NC=NC(=C2N=C1SC3=C(C=C4C(=C3)OCO4)I)N
2.2 Other Identifiers
2.2.1 UNII
06IVK87M04
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Pu H71

2. Pu-h71

2.3.2 Depositor-Supplied Synonyms

1. Pu-h71

2. 873436-91-0

3. Pu-h 71

4. Pu H71

5. Zelavespib

6. Puh-71

7. Pu-h-71

8. 8-((6-iodobenzo[d][1,3]dioxol-5-yl)thio)-9-(3-(isopropylamino)propyl)-9h-purin-6-amine

9. Chembl200102

10. Cas#873436-91-0

11. 06ivk87m04

12. 6-amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-n-(1-methylethyl)-9h-purine-9-propanamine

13. Cas# 873436-91-0

14. 8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9-(3-(isopropylamino)propyl)-9h-purin-6-amine

15. 8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-9-[3-(isopropylamino)propyl]-9h-purin-6-amine

16. 8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine

17. H71

18. Unii-06ivk87m04

19. 2fwz

20. Nsc 750424

21. Zelavespib [inn]

22. Puh71

23. Schembl1857579

24. Pu-h71, D6

25. Dtxsid20236288

26. Ex-a315

27. Hms3653n04

28. Bcp03616

29. Nsc 750424-d6

30. Bdbm50180302

31. Nsc752199

32. S8039

33. Zinc13679213

34. Akos024457431

35. Ccg-269784

36. Cs-0546

37. Db12638

38. Nsc-752199

39. Sb17115

40. Ncgc00371072-06

41. Ac-33112

42. Bs-17694

43. Da-41005

44. Hy-11038

45. Bcp0726000178

46. Ft-0700388

47. Sw220214-1

48. J-690375

49. Brd-k36529613-001-01-8

50. Q27236209

51. 8-(6-iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine

52. 1-{2-[2-(2-fluoroethyl)-2h-tetrazol-5-yl]ethyl}-3-{5-[3-fluoro-4-(methylsulfonyl)phenyl]-4-methyl-1,3-thiazol-2-yl}urea

53. 8-(6-iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropyl-aminopropyl-d6)adenine (pu-h71-d6)

54. 8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-{3-[(1-methylethyl)amino]propyl}-9h-purin-6-amine

2.4 Create Date
2006-10-13
3 Chemical and Physical Properties
Molecular Weight 512.4 g/mol
Molecular Formula C18H21IN6O2S
XLogP33.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count7
Exact Mass512.04914 g/mol
Monoisotopic Mass512.04914 g/mol
Topological Polar Surface Area125 Ų
Heavy Atom Count28
Formal Charge0
Complexity521
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY